Merck & Co., Inc. (MRK) stock analysis

In our weekly check, Merck & Co., Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 5.

About Merck & Co., Inc.

Merck & Co., Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as MRK.

What our checks show for MRK

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-02

Similar companies

NVS · AZN · ABBV · AMGN · GILD · JNJ

Questions

What grade does Merck & Co., Inc. (MRK) have?

In our weekly check, Merck & Co., Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 5. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of MRK stock?

This week's biggest flags for Merck & Co., Inc.: Margins falling, Thin margins, Dividend stretched. In total 11 of 25 checks show a warning or a red flag.

What does Merck & Co., Inc. do?

Merck & Co., Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as MRK.

When does Merck & Co., Inc. report earnings next?

The next earnings report is expected on 2027-02-02. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis